RADX

Radiopharm Theranostics
$3.66
+$0.11 (+3.1%)Jul 27, 2026

Key metrics

The numbers that frame RADX today
52wk Low
$2.73
52wk High
$16.25

RADX stock rating

How RADX scores on quality, value, growth, momentum and financial health
n/aout of 10
No overall ratingNeutral business, valuation unclear
QualityNo scoren/a/10
GrowthNo scoren/a/10
MomentumFair3.4/10
ValueNo scoren/a/10
Financial HealthNo scoren/a/10

Growth

Revenue and earnings trend for RADX
RevenueNet income
See the full growth breakdown

Revenue and earnings trends, margins and the multi-year trajectory - free with an account.

Create a free account
Free foreverNo card required
Already a member? Log in

Cash flow & returns

Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture

Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.

Create a free account
Free foreverNo card required
Already a member? Log in

Insider trading

Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade

See who is buying and selling, how much, and when - updated as new filings land.

Create a free account
Free foreverNo card required
Already a member? Log in

Frequently asked questions

Plain-English answers about RADX
Is Radiopharm Theranostics a good buy?
No. Radiopharm Theranostics has weak momentum.
What is the 52-week high for RADX stock?
The 52-week high for Radiopharm Theranostics is $16.25. The current close of $3.66 is 77.5% below that high.
What is the 52-week low for RADX stock?
The 52-week low for Radiopharm Theranostics is $2.73. The current close of $3.66 is 34.1% above that low.